TRCT
OFIX icon

Tower Research Capital (TRC)’s Orthofix Medical OFIX Stock Holding History

Tower Research Capital (TRC)’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40.2K Buy
3,509
+405
+13% +$5.35K ﹤0.01% 2940
2025
Q4 		$47.1K Sell
3,104
-2,123
-41% -$32.4K ﹤0.01% 2466
2025
Q3 		$76.5K Buy
5,227
+1,968
+60% +$25.8K ﹤0.01% 2207
2025
Q2 		$36.3K Buy
3,259
+2,076
+175% +$25.7K ﹤0.01% 3243
2025
Q1 		$19.3K Sell
1,183
-7,275
-86% -$128K ﹤0.01% 3006
2024
Q4 		$148K Buy
8,458
+4,627
+121% +$80.5K ﹤0.01% 1907
2024
Q3 		$59.8K Sell
3,831
-3,540
-48% -$56.7K ﹤0.01% 2624
2024
Q2 		$97.7K Buy
7,371
+6,989
+1,830% +$95.8K ﹤0.01% 2603
2024
Q1 		$5.55K Sell
382
-23,394
-98% -$323K ﹤0.01% 4526
2023
Q4 		$321K Buy
23,776
+19,556
+463% +$230K ﹤0.01% 1726
2023
Q3 		$54.3K Sell
4,220
-8,268
-66% -$149K ﹤0.01% 2482
2023
Q2 		$226K Buy
12,488
+11,531
+1,205% +$215K 0.01% 1476
2023
Q1 		$16K Sell
957
-12,930
-93% -$253K ﹤0.01% 3725
2022
Q4 		$285K Buy
13,887
+12,506
+906% +$221K 0.01% 1057
2022
Q3 		$27K Sell
1,381
-7,177
-84% -$161K ﹤0.01% 3695
2022
Q2 		$201K Buy
8,558
+1,857
+28% +$53.2K ﹤0.01% 1769
2022
Q1 		$220K Buy
6,701
+6,022
+887% +$193K ﹤0.01% 1655
2021
Q4 		$22K Sell
679
-735
-52% -$24.6K ﹤0.01% 3566
2021
Q3 		$54K Buy
1,414
+565
+67% +$22.5K ﹤0.01% 2897
2021
Q2 		$35K Sell
849
-810
-49% -$34.2K ﹤0.01% 3327
2021
Q1 		$72K Buy
1,659
+146
+10% +$6.44K ﹤0.01% 2832
2020
Q4 		$65K Sell
1,513
-12,780
-89% -$467K ﹤0.01% 2822
2020
Q3 		$445K Buy
14,293
+11,781
+469% +$365K ﹤0.01% 1807
2020
Q2 		$81K Buy
+2,512
New +$83.4K ﹤0.01% 2645
2019
Q4 		– Sell
-118
Closed -$6K – 4133
2019
Q3 		$6K Sell
118
-896
-88% -$46.2K ﹤0.01% 3232
2019
Q2 		$54K Buy
+1,014
New +$53.9K ﹤0.01% 1540
2019
Q1 		– Sell
-76
Closed -$4K – 4145
2018
Q4 		$4K Buy
+76
New +$4.32K ﹤0.01% 3057
2018
Q3 		– Sell
-371
Closed -$21K – 4116
2018
Q2 		$21K Sell
371
-815
-69% -$46.4K ﹤0.01% 2410
2018
Q1 		$70K Buy
1,186
+1,058
+827% +$59.3K 0.01% 1491
2017
Q4 		$7K Sell
128
-3,606
-97% -$187K ﹤0.01% 2749
2017
Q3 		$177K Buy
+3,734
New +$176K 0.01% 859
2017
Q2 		– Sell
-198
Closed -$8K – 3220
2017
Q1 		$8K Sell
198
-306
-61% -$11.3K ﹤0.01% 1920
2016
Q4 		$18K Sell
504
-26
-5% -$987 ﹤0.01% 2243
2016
Q3 		$23K Sell
530
-1,668
-76% -$74.4K ﹤0.01% 1531
2016
Q2 		$94K Buy
2,198
+1,807
+462% +$78.6K 0.01% 1142
2016
Q1 		$16K Sell
391
-198
-34% -$7.76K ﹤0.01% 1518
2015
Q4 		$23K Buy
+589
New +$22K ﹤0.01% 1155
2015
Q3 		– Sell
-137
Closed -$5K – 4552
2015
Q2 		$5K Sell
137
-725
-84% -$24.9K ﹤0.01% 3254
2015
Q1 		$31K Buy
+862
New +$27.1K ﹤0.01% 1879
2014
Q2 		– Sell
-2,248
Closed -$68K – 4467
2014
Q1 		$68K Buy
+2,248
New +$51.8K 0.01% 897
2013
Q4 		– Sell
-5,449
Closed -$113K – 4799
2013
Q3 		$113K Buy
5,449
+5,320
+4,124% +$129K 0.01% 1185
2013
Q2 		$3K Buy
+129
New +$3.86K ﹤0.01% 3308

Other funds holding OFIX

ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tower Research Capital (TRC)'s OFIX Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Orthofix Medical (OFIX) stake by 13% in Q1 2026, buying an estimated $5.35K and bringing the position to 3,509 shares worth $40.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2940.

Tower Research Capital (TRC) first reported a position in OFIX in Q2 2013 and has held it in 42 quarters since. The position peaked at $445K in Q3 2020. 147 funds tracked by Wall St. Rank hold OFIX as of Q1 2026.

  • Tower Research Capital (TRC) held 3,509 shares of Orthofix Medical worth $40.2K as of Q1 2026.
  • Tower Research Capital (TRC) bought 405 Orthofix Medical shares in Q1 2026, an estimated $5.35K.
  • Orthofix Medical made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #2940 holding.
  • Tower Research Capital (TRC) first reported a position in Orthofix Medical in Q2 2013 and has held it in 42 quarters since.
  • Tower Research Capital (TRC)'s Orthofix Medical position peaked at $445K in Q3 2020.
  • 147 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.